These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
202 related items for PubMed ID: 3456067
1. Effect of microsomal enzyme inducers on the urinary excretion pattern of mutagenic metabolites of the carcinogen 2,4-toluenediamine. Reddy TV, Ramanathan R, Benjamin T, Grantham PH, Weisburger EK. J Natl Cancer Inst; 1986 Feb; 76(2):291-7. PubMed ID: 3456067 [Abstract] [Full Text] [Related]
2. Mutagenicity of urine from rats after administration of 2,4-diaminoanisole: the effect of microsomal enzyme inducers. Reddy TV, Benjamin T, Grantham PH, Weisburger EK, Thorgeirsson SS. Mutat Res; 1980 Dec; 79(4):307-17. PubMed ID: 7003374 [Abstract] [Full Text] [Related]
3. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA. Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702 [Abstract] [Full Text] [Related]
4. Modification of the mutagenicity and teratogenicity of cyclophosphamide in rats with inducers of the cytochromes P-450. Hales BF. Teratology; 1981 Aug; 24(1):1-11. PubMed ID: 7029774 [Abstract] [Full Text] [Related]
5. Differential effects of cytochrome P450-inducers on promutagen activation capabilities and enzymatic activities of S-9 from rat liver. Ong T, Mukhtar M, Wolf CR, Zeiger E. J Environ Pathol Toxicol; 1980 Aug; 4(1):55-65. PubMed ID: 7441130 [Abstract] [Full Text] [Related]
6. Acitretin elimination in Sprague-Dawley rats pretreated with phenobarbital or beta-naphthoflavone. Small DS, McNamara PJ. Drug Metab Dispos; 1995 Apr; 23(4):465-72. PubMed ID: 7600913 [Abstract] [Full Text] [Related]
7. Disposition of 8-methoxypsoralen in the rat. Induction of metabolism in vivo and in vitro and identification of urinary metabolites by thermospray mass spectrometry. Mays DC, Hecht SG, Unger SE, Pacula CM, Climie JM, Sharp DE, Gerber N. Drug Metab Dispos; 1987 Apr; 15(3):318-28. PubMed ID: 2886306 [Abstract] [Full Text] [Related]
8. Human liver S-9 metabolic activation: proficiency in cytogenetic assays and comparison with phenobarbital/beta-naphthoflavone or aroclor 1254 induced rat S-9. Johnson TE, Umbenhauer DR, Galloway SM. Environ Mol Mutagen; 1996 Apr; 28(1):51-9. PubMed ID: 8698047 [Abstract] [Full Text] [Related]
9. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice. Irwin RD. Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105 [Abstract] [Full Text] [Related]
11. Characterization of mutagenic glucuronide formation from benzo(a)pyrene in the nonrecirculating perfused rat liver. Kari FW, Kauffman FC, Thurman RG. Cancer Res; 1984 Nov; 44(11):5073-8. PubMed ID: 6488167 [Abstract] [Full Text] [Related]
12. Metabolic activation of mutagenic tryptophan pyrolysis products by rat liver microsomes. Ishii K, Yamazoe Y, Kamataki T, Kato R. Cancer Res; 1980 Jul; 40(7):2596-600. PubMed ID: 6771001 [Abstract] [Full Text] [Related]
16. Acetaminophen hepatotoxicity: influence of phenobarbital and beta-naphthoflavone treatment in obese and lean Zucker rats. Tuntaterdtum S, Chaudhary IP, Cibull M, Robertson LW, Blouin RA. Toxicol Appl Pharmacol; 1993 Dec; 123(2):219-25. PubMed ID: 8248929 [Abstract] [Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program . Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653 [Abstract] [Full Text] [Related]
18. NTP Technical Report on the metabolism, toxicity and predicted carcinogenicity of diazoaminobenzene (CAS No. 136-35-6). Ress NB, National Toxicology Program. Toxic Rep Ser; 2002 Sep; (73):1-23, A1-C6. PubMed ID: 12370695 [Abstract] [Full Text] [Related]
19. Characterization of verlukast metabolites arising from an epoxide intermediate produced with hepatic microsomes from beta-naphthoflavone-treated rodents (P-4501A1). Nicoll-Griffith DA, Chauret N, Yergey JA, Trimble LA, Favreau L, Zamboni R, Grossman SJ, Drey J, Herold E. Drug Metab Dispos; 1993 Sep; 21(5):861-7. PubMed ID: 7902249 [Abstract] [Full Text] [Related]
20. Metabolism, disposition, and mutagenicity of 2,6-diaminotoluene, a mutagenic noncarcinogen. Cunningham ML, Burka LT, Matthews HB. Drug Metab Dispos; 1989 Sep; 17(6):612-7. PubMed ID: 2575496 [Abstract] [Full Text] [Related] Page: [Next] [New Search]